Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK2 | P52789 | 3/20 | 0.46 |
| ▸ | HK1 | P19367 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 14/20 | 0.45 |
| ▸ | CA2 | P00918 | 14/20 | 0.45 |
| ▸ | CA9 | Q16790 | 10/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30524947 | 1.00 | HK2 (0.46) | HK2HK1CA1CA2CA9 | |
| SCHEMBL25867392 | 0.85 | CA2 (0.60) | CA1CA2CA9LGALS3 | |
| SCHEMBL23705148 | 0.85 | CA2 (0.60) | CA1CA2CA9LGALS3 | |
| SCHEMBL18251464 | 0.81 | CA1 (0.43) | HK2HK1CA1CA2CA9 | |
| SCHEMBL24767825 | 0.81 | CA1 (0.43) | HK2HK1CA1CA2CA9 | |
| SCHEMBL21191298 | 0.81 | CA1 (0.55) | CA1CA2CA9 | |
| SCHEMBL17833049 | 0.79 | CA1 (0.43) | HK2HK1CA1CA2CA9 | |
| SCHEMBL19708450 | 0.79 | CA1 (0.41) | HK2HK1CA1CA2CA9 | |
| B-D-Galactose SCHEMBL28463978 | 0.77 | CA1 (0.64) | CA1CA2CA9 | |
| SCHEMBL23705267 | 0.75 | CYP3A4 (0.44) | CA1CA2FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4104865-A1 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | AbbVie Inc. (US) | 2022-12-21 | — | — | EP | disclosed |